184 related articles for article (PubMed ID: 8087520)
21. Toxicities in RTOG combined-modality trials for inoperable non-small-cell lung cancer.
Byhardt RW
Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):116-20. PubMed ID: 10550835
[TBL] [Abstract][Full Text] [Related]
22. Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
Bonomi P; Reddy S; Faber LP
Hematol Oncol Clin North Am; 1990 Dec; 4(6):1143-58. PubMed ID: 1962781
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
Mornex F
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
[No Abstract] [Full Text] [Related]
24. Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer.
Ahn YC; Park K; Kim DY; Kim KM; Kim J; Shim YM; Lee KS; Han J; Kim HJ; Kwon J; Lim DH; Noh YJ; Lee JE; Huh SJ
Acta Oncol; 2001; 40(5):588-92. PubMed ID: 11669330
[TBL] [Abstract][Full Text] [Related]
25. Radiosensitization by cytotoxic drugs. The EORTC experience by the Radiotherapy and Lung Cancer Cooperative Groups.
Schaake-Koning C; van den Bogaert W; Dalesio O; Festen J; Hoogenhout J; van Houtte P; Kirkpatrick A; Koolen M; Maat B; Nijs A
Lung Cancer; 1994 Mar; 10 Suppl 1():S263-70. PubMed ID: 8087519
[TBL] [Abstract][Full Text] [Related]
26. Surgical considerations after preoperative treatment.
Ginsberg RJ
Lung Cancer; 1994 Mar; 10 Suppl 1():S213-7. PubMed ID: 8087513
[TBL] [Abstract][Full Text] [Related]
27. Amifostine in chemoradiation therapy for non-small cell lung cancer: review of experience and design of a phase II trial assessing subcutaneous and intravenous bolus administration.
Werner-Wasik M; Langer C; Movsas B
Semin Oncol; 2005 Apr; 32(2 Suppl 3):S105-8. PubMed ID: 16015544
[TBL] [Abstract][Full Text] [Related]
28. Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer.
Choy H; LaPorte K; Knill-Selby E; Mohr P; Shyr Y
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):90-6. PubMed ID: 10210546
[TBL] [Abstract][Full Text] [Related]
29. O02.03 Value of adding erlotinib to thoracic radiation therapy with chemotherapy for stage III non-small cell lung cancer: a prospective phase II study.
Clin Adv Hematol Oncol; 2014 Jan; 12(1 Suppl 1):6. PubMed ID: 24852396
[No Abstract] [Full Text] [Related]
30. Radiation dose in non-small cell lung cancer: too much of a good thing?
Dilling TJ
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):979-82. PubMed ID: 25539360
[No Abstract] [Full Text] [Related]
31. Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).
Zehentmayr F; Söhn M; Exeli AK; Wurstbauer K; Tröller A; Deutschmann H; Fastner G; Fussl C; Steininger P; Kranzinger M; Belka C; Studnicka M; Sedlmayer F
Radiat Oncol; 2015 May; 10():121. PubMed ID: 26018527
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin and vinorelbine followed by radiotherapy in the treatment of stage III-B non-small-cell lung cancer patients.
Felip E; Del Campo JM; Bodi R; Vera R; Casado S; Rubio D
Am J Clin Oncol; 1997 Aug; 20(4):404-6. PubMed ID: 9256899
[TBL] [Abstract][Full Text] [Related]
33. Radiation therapy for non-small cell lung cancer (NSCLC).
Choy H; Chakravarthy A; Kim JS
Cancer Treat Res; 2001; 105():121-48. PubMed ID: 11224985
[No Abstract] [Full Text] [Related]
34. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial.
Rosenman JG; Halle JS; Socinski MA; Deschesne K; Moore DT; Johnson H; Fraser R; Morris DE
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):348-56. PubMed ID: 12243807
[TBL] [Abstract][Full Text] [Related]
35. Combination of radiotherapy and chemotherapy in locally advanced NSCLC.
Kepka L; Sprawka A; Casas F; Abdel-Wahab S; Agarwal JP; Jeremic B
Expert Rev Anticancer Ther; 2009 Oct; 9(10):1389-403. PubMed ID: 19827998
[TBL] [Abstract][Full Text] [Related]
36. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer].
Kawahara M
Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104
[TBL] [Abstract][Full Text] [Related]
37. Combined treatment with chemotherapy and neutron irradiation for limited non-small-cell lung cancer: a Southwest Oncology Group Study.
Livingston RB; Griffin BR; Higano CS; Laramore GE; Rivkin SE; Goldberg RS; Schulman SF
J Clin Oncol; 1987 Nov; 5(11):1716-24. PubMed ID: 2824705
[TBL] [Abstract][Full Text] [Related]
38. [Endoscopic findings of esophagitis in concurrent chemo-radiotherapy for lung cancer].
Watanabe H; Hirota S; Soejima T; Honda K; Kono K; Hishikawa Y; Obayasi K; Takada Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 May; 58(6):271-6. PubMed ID: 9656695
[TBL] [Abstract][Full Text] [Related]
39. Concomitant chemoradiotherapy for non-small cell lung cancer.
Vokes EE; Haraf DJ; Hoffman PC; Bitran JD; Ferguson MK; Golomb HM
Lung Cancer; 1994 Mar; 10 Suppl 1():S253-61. PubMed ID: 8087518
[TBL] [Abstract][Full Text] [Related]
40. Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.
Patel AB; Edelman MJ; Kwok Y; Krasna MJ; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1106-12. PubMed ID: 15519781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
